IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer
Giulia Becherucci(University of Padua), Daunia Verdi(ASL Roma), Salvatore Pucciarelli(Azienda Ospedale - Università Padova), Maurizio Zizzo(Azienda Sanitaria Unità Locale di Reggio Emilia), Ivana Cataldo(Ospedale SS. Annunziata), Angelo Paolo Dei Tos(University of Padua), Giulia Pozza(University of Padua), Melania Scarpa(University of Padua), Francesca Bergamo(Istituto Oncologico Veneto), Cesare Ruffolo(Ca' Foncello Hospital), Beatrice Salmaso(Ospedale Santa Maria della Misericordia di Rovigo), Astghik Stepanyan(University of Padua), Mario Godina(ASL Roma), Marco Massani(AULSS 2 Marca Trevigiana), Silvia Negro(University of Padua), Stefano Brignola(University of Padua), Valentina Chiminazzo(University of Padua), Dario Parini(Ospedale Santa Maria della Misericordia di Rovigo), Roberto Merenda(Ospedale Civile di Venezia), Tommaso Stecca(Ca' Foncello Hospital), Giorgio Rivella(University of Padua), Antonio Scapinello(Istituto Oncologico Veneto), Matteo Fassan(University of Padua), Luca Dal Santo(University of Padua), Pierluigi Pilati(Istituto Oncologico Veneto), Gianluca Businello(University of Padua), Gaya Spolverato(University of Padua), Federico Scognamiglio(University of Padua), Andromachi Kotsafti(Istituto Oncologico Veneto), Luca Facci(University of Padua), Ottavia De Simoni(Istituto Oncologico Veneto), Isabella Mondi(Ospedale di Mirano), Giovanni Pirozzolo(Ottawa Hospital), Alfonso Recordare(Ca' Foncello Hospital), Imerio Angriman, Boris Franzato(Istituto Oncologico Veneto), Giovanni Tagliente(AULSS 2 Marca Trevigiana), Giovanni Bordignon(AULSS 2 Marca Trevigiana), Chiara Vignotto(University of Padua), Isacco Maretto(University of Padua), Vincenza Guzzardo(University of Padua), Anna Pozza(University of Padua), Valerio Pellegrini(University of Padua), Ceccon Carlotta(University of Padua), Francesco Marchegiani, Laurino Licia(Azienda Ospedale - Università Padova), Roberta Salmaso
Cited by 2
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k